ML18198A067

From kanterella
Jump to navigation Jump to search
608789 Amendment No. 56 for Mclaren Central Michigan to License No. 21-08966-01
ML18198A067
Person / Time
Site: 03002078
Issue date: 07/16/2018
From: Forster S A
NRC/RGN-III
To:
Mclaren Central Michigan
References
608789
Download: ML18198A067 (3)


Text

NRC FORM 374 U.S. NUCLEAR REGULATORY COMMISSION MATERIALS LICENSE PAGE 1 OF 3 . PAGES Amendment No. 56 Pursuant to the Atomic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Public Law 93-438), and Title 10, Code of Federal Regulations, Chapter I, Parts 30, 31, 32, 33, 34, 35, 36, 37, 39, 40, 70 and 71, and in reliance on statements and representations heretofore made by the licensee, a license is hereby issued authorizing the licensee to receive, acquire, possess, and transfer byproduct, source, and special nuclear material designated below; to use such material for the purpose(s) and at the place(s) designated below; to deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part(s). This license shall be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954, as amended, and is subject to all applicable rules, regulations.

and orders of the Nuclear Regulatory Commission now or hereafter in effect and to any conditions specified below. Licensee 1. McLaren Central Michigan 2. 1221 South Dr. Mount Pleasant, Ml 48858-3238

6. Byproduct, source, and/or special nuclear material A. Any byproduct material permitted by 10 CFR 35.100 B. Any byproduct material permitted by 10 CFR 35.200 7. A. Any B. Any In accordance with letter dated 4. Expiration Date: July 31, 2024 May 15L20t,* t-----------+-+-~
5. Docket No.: 030-02078
3. License number: 21-08966-=or; amended in its entirety to reacf -follows: , ¢o~rn¢t,Js . Reference No.: 9. Authorized use A. For use in uptake, dilution and excretion studies permitted by 1 O CFR 35.100. B. For use in imaging and localization studies permitted by 10 CFR 35.200. 10. A. Licensed material listed in Subitem Nos. 6.A. through 6.B. may be used at the licensee's facilities located at Central Michigan Community Hospital, 1221 South Dr., Mt. Pleasant, Ml 48858. B. Licensed material listed in Subitem Nos. 6.A. through 6.B. may also be used at the licensee's facilities located at 315 E Warwick Dr., Alma, Ml 48801. 11. The Radiation Safety Officer (RSO) for this license is James M. Botti, M.S.

NRC FORM 374A U.S. NUCLEAR REGULATORY COMMISSION MATERIALS LICENSE SUPPLEMENTARY SHEET License Number 21-08966-01 Amendment No. 56 12. Licensed material shall only be used by, or under the superv~~ion

?;I: Docket or Reference Number 030-02078

  • <:~ ~t*b L. A. Individuals permitted to work as authorized

~~~accordance with 10 C~35.,J3 and 10 CFR 35.14. '*' ,,.,)Ii ,) -"' lt,c1 .ir ' B. The following individuals are authorize~ers for the material and medical uses a's1~icated:

Authorized User(M.D.,D.O.,etc.)

Mate* 1 and Use Beatrix Araiza, M.D. IL),10 CFR 35.2 * 'C' '"s'.01_ 0'"~,,, ,'"!,,! =,, l Richard R. Black, M.D. . 110 gFR ~5. Mana D.P. Duque, M.D. Brian Ewy, M.D. Russell Gelormini, D.O. Elizabeth Seed Karashin, D.O. Frederick Laufer, M.D. Thomas Pope, Jr., M.D. Rami Safadi, M.D. Bradford Alan Winans, M.D. Theresa Witt-Tilton, M.D. 10 ~~35.100, 10 CFR 35.200 ,._ .1 F I' 10 CFK 35~1 ~O.,J~ C F 351?00:,, " \ -,;e ', ! ' ' / ~' 10 CFR 35.100 ,10 CFR 35:200 PAGE 2 OF 3 PAGES NRC FORM 374A U.S. NUCLEAR REGULATORY COMMISSION PAGE 3 OF 3 PAGES -MATERIALS LICENSE SUPPLEMENTARY SHEET License Number 21-08966-01 Amendment No. 56 Docket or Reference Number 030-02078

13. Except as specifically provided otherwise in this license, the licensee shall conduct its program in accordance with the statements, representations, and procedures contained in the documents, including any enclosures, listed below. This license condition applies only to those procedures that are required to be submitted in ac~~cef"1iE\t:J re!Julations.

Additionally, this license condition does not limit the licensee's ability to make changes to the radiation P{O~foh program as p"fi./ed for in 10 CFR 35.26. The U.S. Nuclear Regulatory Commission's regulations shall govern unless th(iMements, representations~~

~cedures in the licensee's application and correspondence are more restrictive than th~ft~ulations.

<" A. Application dated January 31, 2014 (Cp14031$

B. Letter dated July 10, 2014 (ML 1420~47) C. Letter dated October 21, 2014 (ML fu95A171)

D. Letter dated November 12, 2014 (~4364A205)

E. Letter dated May 15, 2018 (ML181ijt386)

Date: July 16, 2018 FOR THE U.S. NUCLEAR REGULATORY COMMISSION By:?4Ma, a.~~ Sara A. Forster Region 3